CLINICAL TRIALS PROFILE FOR ALTRENO
✉ Email this page to a colleague
All Clinical Trials for ALTRENO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04096742 ↗ | Altreno for Chest Rejuvenation | Active, not recruiting | Bausch Health Americas, Inc. | Phase 4 | 2019-08-06 | This is a single-center, prospective, double-blind, randomized, vehicle-controlled study to evaluate the efficacy, safety and patient satisfaction of tretinoin 0.05% lotion (Altreno) for chest rejuvenation. |
| NCT04096742 ↗ | Altreno for Chest Rejuvenation | Active, not recruiting | Goldman, Butterwick, Fitzpatrick and Groff | Phase 4 | 2019-08-06 | This is a single-center, prospective, double-blind, randomized, vehicle-controlled study to evaluate the efficacy, safety and patient satisfaction of tretinoin 0.05% lotion (Altreno) for chest rejuvenation. |
| NCT04548349 ↗ | Profiling the Skin Microbiome in Response to Altreno in Acne Patients | Recruiting | Ortho Dermatologics | Phase 4 | 2021-04-23 | The study objective is to characterize the shift in the diversity and abundance of the skin microbial community at baseline and in response to Altreno monotherapy as compared to benzoyl peroxide (BPO) 2.5% leave-on gel monotherapy in acne patients. |
| NCT04548349 ↗ | Profiling the Skin Microbiome in Response to Altreno in Acne Patients | Recruiting | Beth Israel Deaconess Medical Center | Phase 4 | 2021-04-23 | The study objective is to characterize the shift in the diversity and abundance of the skin microbial community at baseline and in response to Altreno monotherapy as compared to benzoyl peroxide (BPO) 2.5% leave-on gel monotherapy in acne patients. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALTRENO
Condition Name
Clinical Trial Locations for ALTRENO
Trials by Country
Clinical Trial Progress for ALTRENO
Clinical Trial Phase
Clinical Trial Sponsors for ALTRENO
Sponsor Name
